what is difference between semaglutide and tirzepatide vs. Semaglutide: What's the Difference? Comparative safety and side effects

Discontinuation rates and BMI correlation

Use 29-31 gauge insulin syringes for subcutaneous injections

North America is expected to dominate the GLP-1 receptor agonist market, accounting for 40.7% of the market share in 2026

Some services may prescribe GLP-1s without a thorough health evaluation or ongoing monitoring

2 GLP-1 receptors are expressed in brain regions involved in satiation, satiety, and reward, including the hypothalamus, brainstem, and mesolimbic pathways

If fatigue persists beyond 68 weeks, discuss with your provider whether dosage reduction, switching to a different GLP-1 formulation, or adding complementary medications may help